TRX Gold Ord Shs V.TRX

RE:RE:RE:insider selling

[shakerman640]

Xtremepicks.com is a penny stock promoting website.

I am quite certain that neither Tribute Pharmaceuticals (Canada) Inc. nor its investor relations service provider (BND Projects Inc.) wholly endorses this questionable advertisement and promotion of the company by that particular website.
______________________

https://ir.stockpr.com/tributepharma/company-news/detail/1844/tribute-pharmaceuticals-engages-bnd-projects-inc-as-investor-relations-service-provider-and-grants-options-to-certain-officers-and-directors

MILTON, ONTARIO -- (Marketwired) -- 01/29/15 --

Tribute Pharmaceuticals Canada Inc. (OTCQB:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US, today announced that it has retained BND Projects Inc. ("BND") to provide it with investor relations services. The services to be provided by BND include (i) introducing the Company to the Canadian investment community, (ii) updating the investor base on a regular basis about the Company's fundamentals and goals and milestones, (iii) organizing investor road shows for the Company's management and (iv) assisting with the preparation of corporate communications and presentations.

BND is a Canadian consulting firm based in the Greater Toronto Area founded by Christina Cameron and which is owned by Ms. Cameron. Ms. Cameron, a life sciences capital markets expert with over 14 years of experience in investor relations and investment banking, will be providing the services under the agreement. BND and Ms. Cameron act at arm's length to the Company. BND and BND's principals have the right and expect to, from time to time, purchase Tribute's securities for investment purposes. The principals of BND currently hold a total of 12,500 shares of Tribute.

The agreement with BND, which is subject to the approval of the TSX Venture Exchange, has a thirteen month term and can be terminated by either party on 30 days prior notice. BND will receive a fee of $5,000 per month for the first six months (and nothing thereafter) payable in arrears and will be issued 50,000 options under the Company's stock option plan. Such options will have an exercise price of C$0.62 per share (being the closing price of the Company's common shares on January 28, 2014).
____________________

You can find the Tribute Pharmaceuticals (Canada) Inc. advertisement by Xtremepicks.com at the following link:

https://www.xtremepicks.com/archives/9493
_______________________________________

https://www.xtremepicks.com/about

About

Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. We provide financial and investor relations services for small to mid-cap stocks with weekly and special newsletters to keep you informed of the latest movers. Sign up to our Free Newsletter at https://www.xtremepicks.com

For Advertising and Media relations please contact Direct Global Media at [e-mail]

Our Office is located at

Xtremepicks.com

7 New Road

Belize City, Belize

You can also contact us via email at [e-mail]